-
The FCA’s CEO Nikhil Rathi said the regulator could disclose information on listed firms that miss diversity targets for the make-up of their boards.
-
Amid three regulatory consultations for the legacy market and the threat of s166 reviews for certain Part VII transfers, the legacy market is reaching a turning point.
-
Discussions with industry and in-country partners have so far foregrounded parametric solutions.
-
PRA director Gareth Truran has outlined the dangers of cutting capital requirements for certain assets for insurers, in a speech on specific Solvency II reforms.
-
The European Commission wants to incentivise the insurance sector to invest in the post-pandemic recovery.
-
An investigation by Germany’s financial watchdog BaFin is looking across multiple departments of Allianz’s business, according to Reuters.
-
The regulator said many firms will not be ready to meet the 1 October deadline for new product governance rules.
-
The questionnaire follows a market impact study, as the PRA said there are areas where it needs further insights to inform Solvency II reforms.
-
The PRA has proposed that where non-life legacy transfer deals involve a carrier in run-off, the acquirer may have to go through a Section 166 review under certain circumstances.
-
Insurers said it’s too early to talk loss quantum, but believe they are well poised to deal with any future losses.
-
The regulator has set out timelines and the high-level scope for its 2022 stress-testing exercise with insurers.
-
The regulator’s proposals also suggest there should be at least one senior board member from a non-white ethnic minority background at every listed firm.